| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/27/2006 | US20060088513 Antiallergic composition |
| 04/27/2006 | US20060088511 Cancer therapy sensitizer |
| 04/27/2006 | US20060088504 Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein Al, very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol |
| 04/27/2006 | US20060088472 E7 regulation of p21 cip1 through akt |
| 04/27/2006 | US20060088442 Chemical thermal desorption system |
| 04/27/2006 | US20060086624 Techniques to improve polyurethane membranes for implantable glucose sensors |
| 04/27/2006 | DE19741739B4 Supramolekulares Paarungssystem, dessen Herstellung und Verwendung Supramolecular mating system, its preparation and use |
| 04/27/2006 | CA2855748A1 Primers, probes and methods for nucleic acid amplification |
| 04/27/2006 | CA2611448A1 Rapid and sensitive detection of bacteria in blood products, urine, and other fluids |
| 04/27/2006 | CA2584993A1 Analytical method and apparatus |
| 04/27/2006 | CA2584984A1 Methods for assembly of high fidelity synthetic polynucleotides |
| 04/27/2006 | CA2584576A1 Reagents and methods for improving reproducibility and reducing mispriming in pcr amplification |
| 04/27/2006 | CA2584569A1 Primers, probes and methods for nucleic acid amplification |
| 04/27/2006 | CA2584562A1 Yeast-based therapeutic for chronic hepatitis c infection |
| 04/27/2006 | CA2584519A1 Method for modification of gamma-secretase activity through inhibition of fkbp13 |
| 04/27/2006 | CA2584512A1 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/27/2006 | CA2584474A1 Atp-metry for detecting and counting viruses |
| 04/27/2006 | CA2584470A1 Atp-metry based on intracellular adenyl nucleotides for detecting and counting cells, use and implementing method for determining bacteria in particular devoid of atp |
| 04/27/2006 | CA2584108A1 Development of sensitive fret sensors and methods of using the same |
| 04/27/2006 | CA2584048A1 Multi-domain amphipathic helical peptides and methods of their use |
| 04/27/2006 | CA2583904A1 Methods and compositions for predicting drug responses |
| 04/27/2006 | CA2583546A1 Enzyme cycling based assays for alpha-methylacyl-coa racemase |
| 04/27/2006 | CA2583208A1 Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders |
| 04/27/2006 | CA2576643A1 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 04/26/2006 | EP1650569A2 Method for determination of cholesterol in low-density lipoprotein |
| 04/26/2006 | EP1650564A1 Mechanochemical type sensor |
| 04/26/2006 | EP1650560A1 Biosensor and production method therefor |
| 04/26/2006 | EP1650314A1 Dynamic determination of analytes using arrays on internal surfaces |
| 04/26/2006 | EP1650313A1 Method and probe set for detecting cancer |
| 04/26/2006 | EP1650312A2 Functional assay of high-density lipoprotein |
| 04/26/2006 | EP1650311A1 Compounds and methods for assessment of Microsatellite Instability (MSI) status |
| 04/26/2006 | EP1650305A1 Mutants of the factor VII activating protease and methods for their detection |
| 04/26/2006 | EP1650303A2 Method for generating a substracted cDNA library and uses of the generated library |
| 04/26/2006 | EP1650300A1 Method of judging risk for onset of drug-induced granulocytopenia |
| 04/26/2006 | EP1650299A1 Method of detecting reaction of dna and dna-binding protein |
| 04/26/2006 | EP1650298A1 Oligonucleotide generators based on U6-type RNA polymerase III promoters |
| 04/26/2006 | EP1650221A2 Novel compounds |
| 04/26/2006 | EP1650200A1 Sulfonate compound and fluorescent probe using the same |
| 04/26/2006 | EP1650197A1 Water-soluble tetrazolium compounds |
| 04/26/2006 | EP1649931A1 Chemical analyzing apparatus for biological substances |
| 04/26/2006 | EP1649746A1 MSH5 ablated mice and uses therefor |
| 04/26/2006 | EP1649403A2 Method for determining metabolic flux affecting substance production |
| 04/26/2006 | EP1649346A2 Methods and systems for applying genetic operators to determine system conditions |
| 04/26/2006 | EP1649292A1 Protocol and apparatus for determining heparin-induced thrombocytopenia |
| 04/26/2006 | EP1649283A2 Method for measuring aromatase activity |
| 04/26/2006 | EP1649260A2 Electrode systems for electrochemical sensors |
| 04/26/2006 | EP1649067A1 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 04/26/2006 | EP1649066A2 Multiplexed molecular beacon assay for detection of pathogens |
| 04/26/2006 | EP1649065A2 Methods for amplifying polymeric nucleic acids |
| 04/26/2006 | EP1649064A2 Markers for detection of gastric cancer |
| 04/26/2006 | EP1649063A2 Diagnosis and treatment methods related to aging (8a) |
| 04/26/2006 | EP1649062A1 Methods and systems for diagnosis of non-cenral nervous system (cns) diseases in cns samples |
| 04/26/2006 | EP1649061A2 Genes as diagnostic tools for autism |
| 04/26/2006 | EP1649060A1 Mrna expression analysis |
| 04/26/2006 | EP1649059A1 Methods and kits for detecting an enzyme capable of modifying a nucleic acid |
| 04/26/2006 | EP1649058A2 Use of silver gene for the authentication of the racial origin of animal populations, and of the derivative products thereof |
| 04/26/2006 | EP1649057A1 Obesity markers and uses thereof |
| 04/26/2006 | EP1649056A1 Methods for amplifying and detecting nucleic acids in microfluidic devices under continuous and non-continuous flow conditions. |
| 04/26/2006 | EP1649055A2 Bio-barcode based detection of target analytes |
| 04/26/2006 | EP1649054A1 Method for diagnosing colorectal cancers |
| 04/26/2006 | EP1649053A2 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 04/26/2006 | EP1649052A1 Methods and kits for predicting the likelihood of successful treatment of cancer |
| 04/26/2006 | EP1649051A2 Determining the sequence of a polynucleotide |
| 04/26/2006 | EP1649050A2 Improved heavymethyl assay for the methylation analysis of the gstpi gene |
| 04/26/2006 | EP1649049A1 Improvements in sensor chips |
| 04/26/2006 | EP1649048A1 Mutation associated with strokes |
| 04/26/2006 | EP1649047A1 Methods for detecting aneuploidy using microparticle multiplex detection |
| 04/26/2006 | EP1649046A1 Microarray devices having controllable reaction volume |
| 04/26/2006 | EP1649045A2 Incorporation of hapten groups during the production of carriers for the determination of analytes |
| 04/26/2006 | EP1649044A1 Pknb kinase and pstp phosphatase and methods of identifying inhibitory substances |
| 04/26/2006 | EP1649043A1 Method for the detection of coliforms and in particular escherichia coli |
| 04/26/2006 | EP1649041A2 Multimeric oxidoreductases |
| 04/26/2006 | EP1649040A2 Assays for the direct measurement of gene dosage |
| 04/26/2006 | EP1649037A2 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 04/26/2006 | EP1649019A2 Improved inhibitor nucleic acids |
| 04/26/2006 | EP1649016A1 Clean-up beads |
| 04/26/2006 | EP1649014A1 A method for diagnosis of tuberculosis by smear microscopy, culture and polymerase chain reaction using processed clinical samples and kit thereof |
| 04/26/2006 | EP1649005A2 P450 oxygenases and methods of use |
| 04/26/2006 | EP1649002A2 Rna processing protein complexes and uses thereof |
| 04/26/2006 | EP1648997A2 Methods of treatment and disgnosis using modulators of virus-induced cellular gene sequences |
| 04/26/2006 | EP1648909A2 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies |
| 04/26/2006 | EP1648510A2 Rg1 antibodies and uses thereof |
| 04/26/2006 | EP1648506A1 Method for treating synovial sarcoma |
| 04/26/2006 | EP1648459A1 Sir2 regulation |
| 04/26/2006 | EP1648388A2 Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax |
| 04/26/2006 | EP1648286A2 Sensitive and rapid biodetection |
| 04/26/2006 | EP1583556A4 Sequences diagnostic for foot and mouth disease |
| 04/26/2006 | EP1535072A4 Probe carrier and method of producing same |
| 04/26/2006 | EP1512010A4 Universal biosensor and methods of use |
| 04/26/2006 | EP1474533B1 Method of determining adenovirus particle concentration |
| 04/26/2006 | EP1468096B1 Selective plant growth using d-amino acids |
| 04/26/2006 | EP1451374A4 Method and device for detecting and monitoring alcoholism and related diseases using microarrays |
| 04/26/2006 | EP1443114B1 Method of cell culture |
| 04/26/2006 | EP1429812A4 Unique properties of stem cells |
| 04/26/2006 | EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 04/26/2006 | EP1412508B1 Molecular vector for the genophenotypic characterisation of v3 sequences of hiv-1 gp120 |
| 04/26/2006 | EP1392853B1 Method for analysis of oligonucleotide analogs |
| 04/26/2006 | EP1390537A4 Methods and compositions for amplification of rna sequences |
| 04/26/2006 | EP1360318B1 Method of detection by enhancement of silver staining |
| 04/26/2006 | EP1315972B8 Method for detecting the activity of active ingredients |